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PURPOSE: To ascertain perioperative morbimortality and identify prognostic factors for mortality among patients ≥55 years who 
undergo non-cardiac surgery. 
METHODS: A retrospective cohort of 403 patients relating to perioperative morbidity-mortality. Data were collected from a 
standardized protocol on gender, age, comorbidities, medications used, smoking, alcohol abuse, chronic use of benzodiazepine, 
nutritional status, presence of anemia, activities of daily living, American Society of Anesthesiology classification, Detsky´s modi-
fied cardiac risk index - American College of Physicians, renal function evaluation, pulmonary risk according to the Torrington 
scale, risk of thromboembolic events, presence of malignant disease and complementary examinations. 
RESULTS: The mean age of the subjects was 70.8 ± 8.1 years. The “very old” (≥80 years) represented 14%. The mortality rate was 
8.2%, and the complication rate was 15.8%. Multiple logistic regression showed that a history of coronary heart disease (OR: 3.75; 
p=0.02) and/or valvular heart disease (OR: 31.79; p=0.006) were predictors of mortality. The American Society of Anesthesiology 
classification was shown to be the best scale to mark risk (OR: 3.01; p=0.016). Nutritional status was a protective factor, in which 
serum albumin increases of 1 mg/dl decreased risk by 63%. 
DISCUSSION: The results indicate that serum albumin, coronary heart disease, valvular heart disease and the American Society 
of Anesthesiology classification could be prognostic predictors for aged patients in a perioperative setting. In this sample, provided 
that pulmonary, cardiac and thromboembolic risks were properly controlled, they did not constitute risk factors for mortality. 
Furthermore, continuous effort to learn more about the preoperative assessment of elderly patients could yield intervention pos-
sibilities and minimize morbimortality.
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INTRODUCTION
In past several decades, it was commonly recommended 
that surgery for the elderly be avoided because of their frailty 
and increased risk when undergoing a major operative pro-
cedure. However, recent advances in anesthetic practice and 
surgical techniques, including minimally invasive surgical 
approaches, have enabled sicker and older patients to be 
eligible for procedures that were more risky in the past.1 
The perioperative care of elderly people is influenced by 
the particular alterations to aging, such as the presence of 
comorbidities, the use of multiple medications and the sever-
ity of the disease requiring intervention. Atypical presenta-
tions of diseases, diminished heart and lung reserves and 
alterations in the pharmacodynamics and pharmacokinetics 
of drugs are also observed.2,3
It must be kept in mind that much of the current manage-
ment during the perioperative period for elderly patients is 
based on data from the non-elderly adult population. There 152
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is a need to define specific parameters for the elderly, and 
particularly for the very old.4
The concern now is that, because an increasing number 
of sicker and older patients are having surgery, perioperative 
morbidity and mortality rates may be increasing. As a result, 
there is a renewed interest in identifying factors associated 
with adverse postoperative outcomes to develop strategies to 
improve the perioperative care of and outcomes for geriatric 
surgical patients. Under these conditions, perioperative eval-
uation gives rise to the need for an comprehensive approach, 
with the objectives of minimizing risk as well as maintaining 
or recovering previous functional abilities.2
Design
This retrospective cohort study investigated perioperative 
morbidity-mortality among elderly inpatients of Hospital das 
Clínicas between February and November 2004. The study 
was conducted by administering a structured preoperative 
evaluation and postoperative follow-up until the outcome of 
death or discharge.
SAMPLE AND METHODS
Preoperative evaluations were performed on patients of 
both sexes aged 55 years and over. The exclusion criterion 
was failure to proceed with surgery. 
After ethical approval, a single researcher reviewed the 
medical records made available by the Medical Archives Ser-
vice and information present in the preoperative assessment 
file, with the objective of retrieving the clinical data.
The following data were collected from a standardized 
protocol: sex, age, comorbidities, medications used, smok-
ing, alcohol abuse, chronic use of benzodiazepine, nutritional 
status, presence of anemia, activities of daily living (ADL), 
American Society of Anesthesiology (ASA) classification, 
Detsky´s modified cardiac risk index – American College 
of Physicians (ACP), pulmonary risk according to the Tor-
rington scale, risk of thromboembolic events, presence of 
malignant disease and complementary examinations (elec-
trocardiogram, chest radiograph, hemogram, urea, creatinine, 
albumin, electrolytes and glycemia).
The primary outcome was the occurrence of in-hospital 
death.
After clinical evaluation and risk estimative, the CARES 
group (Clinical Assessment and Research in Elderly Surgi-
cal patients) applies guidelines focused on minimize risk 
including to star the beta blockade treatment to maintaining 
the heart rate below 70 beats per minute for high and inter-
mediate cardiac risk, as suggest by the international recom-
mendations.8-14 Stress imaging testing like sestamibi SPECT 
scan was indicated in selected cases. 
The chronic renal failure stage ≥ 3 should carefully 
balancing fluids, avoid nephrotoxic drugs and use renal 
clearance to corrected antibiotic.  These patients were see-
ing besides a nephrologist.  The high respiratory risk was 
target to physiotherapy. We oriented non pharmacological 
preventive measures from thromboembolism for all patients 
and heparin therapy for high and intermediate risk. We ac-
companying all patients until discharge and complications 
were registered.
The variables relating to death (p< 0.10) in the univari-
ate analysis were grouped for applying logistic regression, 
and each of the groups was reduced by means of a stepwise 
selection process. Considering the variables thus selected, 
the backward stepwise method was applied to obtain the 
principal predictors of mortality. The Hosmer-Lemeshow 
test was used for adjustment of the end model.
For the statistical analysis, the MINITAB 14 program 
was used for descriptive analysis and comparison between 
patients with opposite outcomes. For continuous variables, 
Student’s t-test or the non-parametric Kruskal-Wallis test 
were used. Qualitative variables were compared using the 
Pearson Chi-Square or Fisher’s exact tests. Two-sided p-
values < 0.05 were considered significant.
RESULTS
Descriptive and univariate analysis
Among 508 patients enrolled, 105 (20.7%) fulfilled the 
exclusion criteria. Thus, 403 patients were studied.
The mean age was 70.8 ± 8.1 years, with a range from 55 
to 92 years. The very elderly (≥ 80 years) represented 14% 
(Table 1). Elective surgery performs 88.9%, 67.2% cases 
were in the digestive system with malignant disease in 58% 
(Table 2).
Women predominated (51%), but there were more deaths 
among men (p= 0.017; OR: 2.26; 95% CI: 1.08 – 4.72). Re-
gardless of age, the number of comorbidities, the presence 
Table 1 - Clinical characteristics of cohort patients, accord-
ing to the outcomes.
SG (n=370) DG (n=33) p-value
Age (years)a 70.7 ± 8.1 72.3 ± 7.3 0.249
Male sex - n (%) 176 (48) 23 (70) 0.017
ADL dependence - n (%) 05 (02) 01 (11) 0.177
Malignancy - n (%) 206 (56) 28 (85) <0.001
SG – survivor group; DG – death group; ADL – activities of daily living; 
a M ± SD -mean ± standard deviation.153
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of malignant disease as a surgical diagnosis and ASA and 
Detsky surgical risk classifications presented similar distri-
butions between the sexes. 
The comorbidities are listed in table 3. The number of 
diseases (3.9 ± 1.7) or the number of medications used (2.6 
± 1.8) per patient did not correlate with death. When specific 
diseases were evaluated, we was found that dyslipidemia, 
chronic kidney disease, valve disease (aortic or mitral), 
anemia, and history of coronary artery disease contributed 
towards increased surgical risk. The use of benzodiazepine 
longer than three months (4.7%), alcoholism (4.7%) and 
current smoking (11.9%) or stop smoking longer than three 
Table 2 – Surgical types evaluated
Type of Surgery  n    %
Digestive system elective 271 67.2
Emergency surgery 44   10.9
Gynecological 38   9.4
Urological 11 2.7
Vascular 10 2.5
Ear, nose and throat 10  2.5
Head and neck 07  1.7
Plastic surgery 07  1.7
Ophthalmological 05 1.2
Table 3 – Cohort patients: comorbidities, according to the 
outcomes
Comorbities  SG n(%) DG n(%) p-value
Hypertension 213 (58) 24 (73) 0.09
Anemia 100 (27) 17 (52) 0.004
Diabetes mellitus 76 (21) 7 (21) 0.93
Dyslipidemia 39 (11) 8 (24) 0.04
Coronary disease 21 (06) 8 (24) <0.001
Cardiac failure 25 (07) 3 (09) 0.47
Hypothyroidism 27 (07) 0 (00) 0.15
COPDa 24 (06) 1 (03) 0.70
Stroke 19 (05) 3 (09) 0.40
Atrial fibrillation  17 (05) 4 (12) 0.08
Chronic kidney disease 
stage ≥3
11 (03) 7 (21) <0.001
Depression 13 (04) 2 (06) 0.35
Body mass index <16 6 (02) 5 (16) <0.001
Dementia 6 (02) 2 (06) 0.13
Heart valve disease 1 (0.3) 3 (09) <0.001
SG - survivor group; DG - death group; a chronic obstructive pulmonary 
disease.
Table 4 – Evolution related to nutritional assessment in the 
cohort
Reference 
values
SG (n=370) 
M ± SD a
DG (n=33) 
M ± SD a
p-value
Body mass index 
– kg/m2    
20–25 24.6±5.3 21.3±5.0 0.011
Hemoglobin – 
g/dL
12–18  12.5±2.2 11.2±2.1 0.002
Albumin – 
g/dL
3.5–5.0 3.7±0.7 2.9±0.9 <0.001
Lymphocytes – 
103 cell/mm3
1.0-3.4 1.7±0.7 1.4±0.7 0.084
SG - survivor group; DG - death group; M ± SD a -mean ± standard devia-
tion.
months (28.3%) did not increase the mortality related to the 
operation.
The nutritional profile (Table 4) was seen to be a good 
prognostic factor, given that the mean hemoglobin, albumin 
and body mass index were lower among the patients who 
died, and these patients presented means that were below the 
reference values normally used. 
General surgical risk, as classified by the ASA (Table 5), 
was shown to be progressively greater in accordance with the 
ASA grading, and it was correlated with mortality.
For Detsky’s modified cardiac risk index, 208 (52%) pa-
tients were classified as low risk, 193 (48%) as intermediate 
risk and 2 (0.5%) as high risk. The mortality rate was 7.2% 
for the low-risk category, 8.8% for those at intermediate risk 
and 50.0% for those at high risk, which did not represent any 
significant difference.
The pulmonary and renal risks were low for most of the 
patients, however the risk of thromboembolism was almost 
high (73%). The risk of thromboembolic events and the high 
renal risk correlated with death, in despite of what was found 
for pulmonary risk (Table 6).  
This sample presented a mortality rate of 8.2% and 
Table 5 – Evolution related to ASA classification
ASA  SG n(%) DG n(%)
I    56 (15) 00 (00)
II 292 (79)  27 (82)
III 22 (06)  05 (15)
IV 00 (00) 01 (03)
                                        Chi-squared for trend p= 0.001
SG – survivor group; DG – death group; ASA – American Society of 
Anesthesiology.154
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a non-fatal complications rate of 15.8% (Table 6). In 
particular, cardiac (6%), renal (5%), pulmonary (7%), op-
erative (wound dehiscence, hemorrhage, fistula, etc; 8%) 
and infectious (14%) complications contributed to greater 
mortality (Table 7).
Multivariate analysis
Multivariate analysis via multiple logistic regression 
(Figure 1) indicated the variables that were prognostic for 
mortality. The presence of coronary disease (odds ratio: 
3.75; p=0.02) almost quadrupled the risk of death, while 
heart valve disease (odds ratio, 31.79; p=0.006) increased 
the risk 31-fold.
Nutritional status was shown to be a protective marker: 
a serum albumin increase of 1 mg/dl decreased the risk of 
mortality by 63%. 
ASA classification was shown to be better for estimating 
prognoses that the other risk scales used. On this scale, a 
one-unit increase tripled the chance of death. 
The Hosmer-Lemeshow test (0.899) showed a good fit, 
99.3% sensitivity, 25.0% specificity and 91.3% accuracy in 
retesting this model on the same sample.
DISCUSSION
The limitations of this study are related to its retrospective 
design, which favors under-diagnosing of complications. For 
instance, the low incidence of delirium (3%) found in this 
population can be cited. It is known that hypoactive delirium is 
a condition that is frequently under-diagnosed by health teams 
and its impact on mortality often ignored.5,6 Nevertheless, the 
deaths inside the hospital (primary outcome) were faithfully 
recorded by the institution. Standardization of the preoperative 
Table 6 – Evolution related to the renal, thromboembolism   
and pulmonary risk
Risk Low n(%) Moderate n(%) High n(%)
Renal risk; p=0.02
SG (n=370) 304 (82) 39 (11) 27 (07)
DG (n=033) 23 (70) 03 (09) 07 (21)
Thromboembolism risk; p<0.001
SG (n=370) 03 (01) 105 (28) 262 (71)
DG (n=033) 00 (00) 02 (06) 31 (94)
Pulmonary risk; p=0.20
SG (n=370) 298 (80) 69 (19) 03 (01)
DG (n=033) 23 (70) 10 (30) 00 (00) 
SG – survivor group, DG – death group.
Table 7 – Complications of cohort patients, according to 
the outcomes
Complication SG n(%) DG n(%) p-value
Infectious 31 (8) 25 (76) <0.001
Surgical 21 (6) 11 (33) <0.001
Pulmonary 16 (4) 13 (39) <0.001
Cardiac 16 (4) 9 (27) <0.001
Renal 5 (1) 15 (45) <0.001
Electrolytic disorders 12 (3) 2 (6) 0.320
Delirium 10 (3) 3 (9) 0.081
Venous thromboembolic 2 (0.5) 1 (3) 0.226
Anesthetic 2 (0.5) 0 (0) 1.000
SG – survivor group; DG – death group.
Figure 1 – Odds of death related to the prognostic factors on perioperative period155
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assessment file and the risk scales used gave uniformity to the 
data and made it easier to collect. 
We worked with the bias that the majority of our patients 
underwent digestive system surgery. Incorporation of other 
surgical groups, such as those who underwent orthopedic 
surgery, urological surgery or neurosurgery, might have 
furnished different perspectives from that observed. Our 
population presented a high mean age and a high rate of 
comorbidities but a good functional capacity. Only 2% of 
our patients were dependent for Activities of Daily Liv-
ing. Some comorbidities are related to worse perioperative 
prognosis as coronary artery disease and nowadays, there 
are many purposes to minimize this risk and the elderly is 
a population that potentially has beneficial effects of such 
interventions.8-14
Among the factors included in the multivariate analy-
sis, the presence of mitral or aortic valve disease can be 
highlighted. The presence of symptomatic valve disease 
increases the surgical risk and involves a complex treatment 
that postpones possible non-cardiac surgery. Goldman’s 
scale contraindicates surgery in patients with severe aortic 
valve disease, and the management of such patients currently 
raises interesting controversies.15-20
A poor nutritional profile is a known risk factor for 
infectious complications and wound dehiscence, thereby 
contributing towards greater perioperative mortality. Nu-
tritional support benefits patients with severe malnutrition 
in perioperative period.21-26 In the present study, there was 
greater correlation between mortality and the body mass 
index, albumin and hemoglobin. Albumin was highlighted in 
the logistic regression, in that an increase of 1 g/dl decreased 
the chance of death by 63%.  
Regarding to the scales used for preoperatively evaluat-
ing the risks, there was a clear correlation between the ASA 
classification and mortality. It scores age and degree of 
clinical impairment by chronic diseases, where brief inter-
ventions generally produce disappointing results. A veterans′ 
study7 also saw the ASA classification as a precise predictor 
of mortality.21-26
The univariate association between thromboembolic risk 
and death reflects the particular criteria that scores high-risk 
(malignant disease, immobilization, cardiac insufficiency, 
prolonged surgery, etc.). The majority (73%) of this study 
population was at high risk, but because of the wide use of 
adequate prophylaxis, only three occurrences of this com-
plication were confirmed (0.7%). In other words, the real 
occurrences of venous thromboembolism were unrelated to 
greater mortality. In the literature, it is predicted that deep 
vein thrombosis will occur at a rate of 10 to 20%, and symp-
tomatic pulmonary thromboembolism will occur at a rate of 
5 to 10% in the absence of prophylaxis.27
The modified Detsky index showed similar mortality 
between low and intermediate risk. This was probably due 
to the advent of the use of beta-blockers, which may sig-
nificantly diminish the risk of perioperative cardiac events 
in patients at intermediate risk. Our group systematically 
indicates the use of beta-blockers for patients at intermedi-
ate and high cardiac risk and suggests that this medication 
should be maintained for patients who are already using it at 
home as suggest by the literature.8-14
Pulmonary risk based upon the Torrington scale was not 
a predictor of mortality. This is in line with the literature and 
the guidelines of the American College of Physicians (2006), 
in which pulmonary risk does not contraindicate surgery. We 
recommend clinical control and respiratory physiotherapy as 
indicated for patients at risk.4,27,28 
We conclude that, provided pulmonary and cardiac 
conditions and the risk of thromboembolism are properly 
controlled, they do not constitute risk factors for mortality. 
Therefore, surgical procedures on elderly people with such 
conditions should not be contraindicated. Instead, risk should 
be managed with a preventive attitude. The impact that 
these clinical interventions produce on mortality predictors 
reinforces the need for a comprehensive approach towards 
the elderly. 
The results indicate that serum albumin, coronary heart 
disease, valvular heart disease and ASA classification could 
be prognostic predictors for aged patients in a perioperative 
setting. Furthermore, continuous efforts to learn more about 
the preoperative assessment of elderly patients could yield 
intervention possibilities and minimize morbimortality. More 
consistent data will come from prospective studies that are 
now in progress at our center. 
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